News
September 21, 2022
PENNCIL TEAM IS LEADING A NATIONAL MULTI-INSTITUTIONAL STUDY TO USE AI TO ADVANCE EARLY DETECTION OF RARE DISEASES.
We are excited to launch this 4-year study, co-led by Peter Merkel at Penn and Jiang Bian at the University of Florida, to take real-world data based evidence generation to its next level of informing clinical practice and decision-making. We will use data from more than 10 health systems with 27 million patients for early detection of rare diseases.
For more information, please see: https://www.pennmedicine.org/news/news-releases/2022/september/researchers-aim-to-use-ai-to-predict-rare-diseases.
Tags:
collaborationRelated Posts
- Postdoctoral Research Fellow Position Available ( March 12, 2021 )
- PhD candidate Mac Edmondson is joining Merck in 2021 ( November 30, 2020 )
- PhD candidate Arielle Marks-Anglin is joining Mathematica in 2021 ( November 30, 2020 )
- Welcome postdoc research fellow Dr. Xiaokang Liu to our PennCIL group! ( July 14, 2020 )
- Welcome postdoc research fellow Dr. Yuchen Yang to our PennCIL group! ( July 14, 2020 )
- PhD student Rui Duan Dissertation Defense will be Held at 2pm on April 8th 2020 ( April 6, 2020 )
- PhD student Rui Duan is Joining Harvard University in August ( April 5, 2020 )
- Dr. Yong Chen was named Fellow of the American Statistical Association ( April 3, 2020 )
- EHR and Polygenic Risk Score for Predicting Disease Risk ( March 31, 2020 )
- Postdoc Fellow Dr. Ray is Joining The University of South Carolina ( March 1, 2020 )
Recent Posts
- PENNCIL TEAM IS LEADING A NATIONAL MULTI-INSTITUTIONAL STUDY TO USE AI TO ADVANCE EARLY DETECTION OF RARE DISEASES.
- Postdoctoral Research Fellow Position Available
- PhD candidate Mac Edmondson is joining Merck in 2021
- PhD candidate Arielle Marks-Anglin is joining Mathematica in 2021
- Welcome postdoc research fellow Dr. Xiaokang Liu to our PennCIL group!